Gemelli Biotech Corp. — Form D

Gemelli Biotech Corp. of Raleigh, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-08. The offering totals $20.0M, of which $18.9M was reported sold. Industry: Biotechnology.

Offering

Filed: 2022-06-08
Form: D
Accession: 0001780605-22-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $20.0M
Amount sold: $18.9M
Remaining: $1.1M
Investors: 121
Date of first sale: 2021-12-07
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-448519

Issuer

Name: Gemelli Biotech Corp.
CIK: 0001780605
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2018
Address: 2009 Fairview Rd. #6099, Raleigh, NC, 27628
Phone: (919) 451-0533

Officers, directors & promoters (8)

Name	Role	Location
Mark Pimentel	Director	Raleigh, NC
Mark Pimentel	Executive Officer	Raleigh, NC
John A Neczesny	Director	Raleigh, NC
Matthew Mitcho	Director	Raleigh, NC
Matthew Mitcho	Executive Officer	Raleigh, NC
Oded A Levy	Director	Raleigh, NC
Ritish A Agarwal	Director	Raleigh, NC
James Laur	Director	Raleigh, NC

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2024-12-02	D/A	$23.9M	$21.2M
2021-03-29	D/A	$5.5M	$5.5M
2021-03-26	D	$5.0M	$5.0M
2019-06-28	D	$3.0M	$1.9M

More